Technology | November 02, 2009

GE Spotlights PET/CT, New Image-Guided Ultrasound System at ASTRO

November 2, 2009 – GE Healthcare is spotlighting its Discovery PET/CT 600, unveiling the new LOGIQ P6 Ultrasound for image-guided radiation therapy, and more technology that demonstrates the potential connections across the cancer care continuum at the American Society for Radiation Oncology (ASTRO) meeting in Chicago, Ill., Nov. 1-5, 2009.

“Oncology care is about making connections,” said Paul Anderson, General Manager of Oncology for GE Healthcare. “It’s about making the connection between the disease, the treatment, the patients and the multi-disciplinary clinical team.”

Advances in radiotherapy treatments have required parallel advancements in imaging, providing oncology specialists with imaging technology that moves from basic qualitative information to deliver high-level quantitative patient data. These refinements have allowed oncologists to better target the therapies by connecting all components that are key to personalized patient cancer treatment. The multi-modality oncology suite connects care from pathways to simulate therapy delivery, to gauging the response to actual treatment, to monitoring its efficacy.

GE’s booth at ASTRO will spotlight the connections between disease and treatment, as well as between clinician and patient. At the same time, broader clinical connections that link patient information, department workflow and oncology management will be demonstrated. Products whose spotlighted advances in cancer diagnostics and care include:
• LightSpeed RT16
A wide bore CT system specifically designed to meet the needs of a Radiation Oncology department for CT simulation. It delivers excellent image quality and the power to support 4D studies, while allowing extra space in the bore for accurate patient positioning. The system’s capabilities, combined with radiation oncology software applications, help enhance image accuracy for radiation therapy planning.
· Signa™ MR Oncology Package
Enhances magnetic resonance imaging for radiation therapy planning and is compatible with the most widely used GE MRI systems. The package consists of a detachable flat-surface patient table with indexed edges, flexible surface coils for high-resolution imaging and treatment positioning aids.
• Discovery PET/CT 600
Features high sensitivity with the next generation of MotionFree technology to deliver a high degree of clinical confidence when simulating therapy.

• LOGIQ® P6 Ultrasound
A small, portable package that handles a broad range of applications, from abdominal to small parts imaging, with exceptional 4-D clarity and definition. LOGIQ P6 supports brachytherapy procedures with report package and compatibility with most stepper device manufacturers.

• Centricity PACS-IW Oncology Workflow

Integrates the web-based design and intuitive interface of PACS-IW with automated PET/CT fusion, analysis and multi-modality reading tools. This integration of oncology image interpretation and review into the multi-modality world of PACS enables clinicians to have easy access to the full set of available clinical information.

Oncology workstation

GE Healthcare will also showcase its powerful oncology workstation that helps reduce time spent on 4D planning and complex multi-modality cases, while streamlining radiation oncology workflow. As a continuous effort to maintain seamless interoperability, GE joined the IHE-RO task force formed by ASTRO for promoting interoperability between vendors. GE Healthcare successfully passed the interoperability testing at the annual IHE-RO connectathon and will continue to work together with IHE-RO to advance these efforts.
• AdvantageSim™ MD

A fast, easy and simple virtual simulation tool that helps streamline workflow from scan to plan. It helps reduce time spent on tasks and helps improve accuracy.

• Advantage 4D

A fast, powerful motion assessment tool that helps make 4D planning routine across the clinical practice.

• Advantage Fusion

Enhances tumor definition by automatically co registering CT, PET and MR images.

“We have a long, diverse relationship with the radiation oncology community,” said Anderson. “GE Healthcare has forged their own connection to this medical specialty by providing advanced tools and solutions that drive productivity and enhance today’s treatment delivery technologies.

Related Content

Siemens Healthineers Announces FDA Clearance of syngo.via VB30 Molecular Imaging Software
Technology | Nuclear Imaging | July 16, 2018
At the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 23-26 in Philadelphia...
Philips North America and GE Healthcare Win IMV PET Imaging ServiceTrak Awards
News | PET Imaging | June 25, 2018
IMV, part of the Science and Medicine Group and a market research and business intelligence provider to the imaging...
FDA Clears New Imaging Functionalities for Biograph mCT PET/CT Systems
Technology | PET-CT | June 21, 2018
Siemens Healthineers will announce U.S. Food and Drug Administration (FDA) clearance of four new system features for...
PET/CT Changes Care for 59 Percent of Suspected Recurrent Prostate Cancer Cases
News | Prostate Cancer | June 13, 2018
A recently presented investigational clinical trial evaluated the impact of 18F fluciclovine positron emission...
Nuclear imaging scan showing very good tissue delineation. Scan performed on a Biograph Vision positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers.

Nuclear imaging scan showing very good tissue delineation. It offers crisp overall image quality and sharply delineates the muscle and fat planes, vertebral margins and end plates, billiary radicals, renal calyces, aortic wall and papillary muscles of the heart. Scan performed on a Biograph Vision positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers.

Technology | PET-CT | June 05, 2018
June 5, 2018 — The U.S.
News | Computed Tomography (CT) | May 21, 2018
The Istituto Oncologico Veneto (IOV) in Padua, Italy, has acquired MILabs’ latest-generation Versatile Emission...
News | Radiopharmaceuticals and Tracers | May 09, 2018
Blue Earth Diagnostics signed an exclusive, worldwide agreement with Scintomics GmbH, Germany, a specialist in...
In scans of a 62-yr-old man with Gleason 4+3 PCa treated with radical prostatectomy, with rising PSA level (1.32) and PSA doubling time of 3.7 months, 64CuCl2-PET/CT images revealed 2 positive small left iliac lymph nodes (A,C), whereas 18F-Choline PET/CT (B,D) was negative (arrows).

In scans of a 62-yr-old man with Gleason 4+3 PCa treated with radical prostatectomy, with rising PSA level (1.32) and PSA doubling time of 3.7 months, 64CuCl2-PET/CT images revealed 2 positive small left iliac lymph nodes (A,C), whereas 18F-Choline PET/CT (B,D) was negative (arrows). Image courtesy of A Piccardo et al., Galliera Hospital, Genoa, Italy.

News | Prostate Cancer | March 07, 2018
An Italian study featured in the March i
Axumin PET Agent Added to NCCN Guidelines for Suspected Recurrent Prostate Cancer
News | PET Imaging | February 21, 2018
Blue Earth Diagnostics announced that Axumin (fluciclovine F 18) injection has been added to the National Comprehensive...
PSMA PET-CT Clearly Differentiates Prostate Cancer from Benign Tissue

68Ga-PSMA PET/CT images showing multifocal PCA in peripheral zone with GS of 5 1 5 5 10. (A and C) Axial PET images. (B and D) Fused PET/CT images. SUVmax of lesion in B was 84.3 and that of lesion in D was 5.7. IRS was 3, and 80% of cells were stained. Credit: Senior author V Prasad, Charité Universitätsmedizin Berlin, Berlin, Germany.

News | PET-CT | February 05, 2018
February 5, 2018 — Using nuclear medicine...
Overlay Init